Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Lakartidningen
|
April 23, 2004
[Apolipoproteins are new and better risk indicators of myocardial infarction]
Göran Walldius, Ingmar Jungner
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 17, 2007
Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy
Göran Walldius, Ingmar Jungner
Current Opinion in Cardiology
|
June 9, 2007
Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke
Göran Walldius, Ingmar Jungner
International Journal of Neonatal Screening
|
February 4, 2021
Gunnar Jungner and the Principles and Practice of Screening for Disease
Lars Jungner, Ingmar Jungner, Martin Engvall, et al.
Annals of Medicine
|
May 19, 2011
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Atherosclerosis
|
September 17, 2010
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Annals of Medicine
|
August 7, 2009
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
European Journal of Heart Failure
|
October 6, 2009
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Cancer Causes & Control : CCC
|
June 21, 2011
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
Mats Lambe, Annette Wigertz, Hans Garmo, et al.
Plos One
|
October 30, 2014
Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort
Håkan Malmström, Göran Walldius, Valdemar Grill, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Lakartidningen
|
April 23, 2004
[Apolipoproteins are new and better risk indicators of myocardial infarction]
Göran Walldius, Ingmar Jungner
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 17, 2007
Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy
Göran Walldius, Ingmar Jungner
Current Opinion in Cardiology
|
June 9, 2007
Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke
Göran Walldius, Ingmar Jungner
International Journal of Neonatal Screening
|
February 4, 2021
Gunnar Jungner and the Principles and Practice of Screening for Disease
Lars Jungner, Ingmar Jungner, Martin Engvall, et al.
Annals of Medicine
|
May 19, 2011
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Atherosclerosis
|
September 17, 2010
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Annals of Medicine
|
August 7, 2009
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
European Journal of Heart Failure
|
October 6, 2009
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Cancer Causes & Control : CCC
|
June 21, 2011
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
Mats Lambe, Annette Wigertz, Hans Garmo, et al.
Plos One
|
October 30, 2014
Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort
Håkan Malmström, Göran Walldius, Valdemar Grill, et al.
Page
of 7